RoslinCT
ApprovedInnovative cell & Gene therapy CDMO solutions for the US and EU markets for clinical and commercial cell therapy development and manufacturing
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $15M
About
Innovative cell & Gene therapy CDMO solutions for the US and EU markets for clinical and commercial cell therapy development and manufacturing
Cell & Gene Therapy
Funding History
1Total raised:$15M
Series A$15MJun 15, 2021